International Medical Industries — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

International Medical Industries (IMI) is a long-established, private medical device manufacturer focused on securing the drug supply chain within pharmacies and hospitals. Its core technology is tamper-evident caps and closures, which have become an industry standard for safeguarding against drug diversion. The company serves a niche but critical segment of the healthcare market, providing essential tools for regulatory compliance (e.g., USP <797> and <800>) and patient safety. With over 50 years of operation, IMI leverages its deep domain expertise and U.S.-based manufacturing to maintain its position as a trusted partner in drug security.

Drug Delivery

Technology Platform

Specialized mechanical and design platform for tamper-evident (TE) closure systems for drug delivery devices (syringes, IV bags). Core technology provides visible, irreversible indication of access to deter drug diversion.

Opportunities

Increased regulatory enforcement of USP <797> and <800> standards drives mandatory adoption of safety and security devices in pharmacies.

The growing focus on combating opioid and hazardous drug diversion creates a sustained need for tamper-evident solutions.

'Made in USA' branding provides a competitive advantage in sectors prioritizing supply chain resilience and quality.

Risk Factors

Heavy reliance on a niche market (compounding pharmacy) subject to regulatory changes.

Competition from other medical device suppliers and potential integration of security features by automated compounding system manufacturers.

Technological disruption if digital or electronic tracking solutions reduce reliance on physical tamper-evident seals.

Competitive Landscape

IMI competes in the niche market of pharmacy compounding supplies and drug security devices. Direct competitors include other suppliers of tamper-evident caps, closures, and fluid transfer devices. Broader competition may come from large, diversified medical device companies and pharmacy automation vendors that could bundle security features. IMI's differentiation is based on its long-standing specialization, U.S. manufacturing, and focus on being a compliance partner.

More companies in Drug Delivery & Formulation →More companies in United States →